The Immuno 2026 Global Virtual Congress on Immuno-Oncology, presented by OncoDaily in partnership with the Parker Institute for Cancer Immunotherapy, will take place online from 24–30 September 2026.

The international congress will bring together experts in cancer immunology, immunotherapy, translational research, clinical oncology, and patient advocacy to examine the next generation of immune-based cancer treatments. Key topics will include checkpoint inhibitor resistance, cellular therapies for hematologic and solid tumors, personalized cancer vaccines, tumor antigen discovery, biomarker-driven treatment selection, combination immunotherapy, and immune-related toxicity management.

Through expert presentations, disease-specific sessions, panel discussions, rapid-fire research talks, and global perspectives, the event will connect scientific discovery with clinical practice while also marking the Parker Institute’s 10th anniversary and its contribution to collaborative cancer immunotherapy research.

Register Now.